Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1

عرض إصدارات أخرى (1)

Background A newly defined congenital myasthenic syndrome (CMS) caused by DPAGT1 mutations has recently been reported. While many other CMSassociated proteins have discrete roles localised to the neuromuscular junction, DPAGT1 is ubiquitously expressed, modifying many proteins, and as such is an une...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Finlayson, S, Palace, J, Belaya, K, Walls, T, Norwood, F, Burke, G, Holton, J, Pascual-Pascual, S, Cossins, J, Beeson, D
التنسيق:	Journal article
اللغة:	English
منشور في:	2013

مواد مشابهة

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1.
حسب: Finlayson, S, وآخرون
منشور في: (2013)

Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates
حسب: Belaya, K, وآخرون
منشور في: (2012)

Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates.
حسب: Belaya, K, وآخرون
منشور في: (2012)

Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.
حسب: Belaya, K, وآخرون
منشور في: (2012)

Congenital myasthenic syndrome caused by mutations in DPAGT.
حسب: Klein, A, وآخرون
منشور في: (2015)

Clinical features in a large Iranian family with a limb-girdle congenital myasthenic syndrome due to a mutation in DPAGT1.
حسب: Basiri, K, وآخرون
منشور في: (2013)

Congenital myasthenic syndromes due to mutations in ALG2 and ALG14
حسب: Cossins, J, وآخرون
منشور في: (2013)

Congenital myasthenic syndromes: an update.
حسب: Finlayson, S, وآخرون
منشور في: (2013)

Congenital myasthenic syndromes due to mutations in ALG2 and ALG14
حسب: Cossins, J, وآخرون
منشور في: (2013)

Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
حسب: Lashley, D, وآخرون
منشور في: (2010)

The congenital myasthenic syndromes.
حسب: Palace, J, وآخرون
منشور في: (2008)

The genetic diagnosis of congenital myasthenic syndromes (CMS)
حسب: Man, S, وآخرون
منشور في: (2005)

CLINICAL FEATURES OF THE SLOW-CHANNEL CONGENITAL MYASTHENIC SYNDROME
حسب: Lashley, D, وآخرون
منشور في: (2009)

The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
حسب: Cossins, J, وآخرون
منشور في: (2012)

Congenital myasthenic syndromes.
حسب: Beeson, D, وآخرون
منشور في: (1997)

Congenital myasthenic syndrome due to mutations in MUSK suggests that the level of MuSK phosphorylation is crucial for governing synaptic structure
حسب: Rodríguez Cruz, PM, وآخرون
منشور في: (2019)

Clinical features of the myasthenic syndrome arising from mutations in GMPPB
حسب: Rodríguez Cruz, P, وآخرون
منشور في: (2016)

A novel cardiac phenotype in patients with GFPT1 or DPAGT1 mutations
حسب: Lewis, A, وآخرون
منشور في: (2014)

Congenital myasthenic syndromes and the neuromuscular junction.
حسب: Cruz, P, وآخرون
منشور في: (2014)

Therapeutic strategies for congenital myasthenic syndromes
حسب: Lee, M, وآخرون
منشور في: (2018)

Congenital myasthenic syndromes and the formation of the neuromuscular junction.
حسب: Beeson, D, وآخرون
منشور في: (2008)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
حسب: Beeson, D, وآخرون
منشور في: (2008)

A nationwide service for the diagnosis and treatment of congenital myasthenic syndromes
حسب: Burke, G, وآخرون
منشور في: (2006)

Mutations in GFPT1 that underlie limb-girdle congenital myasthenic syndrome result in reduced cell-surface expression of muscle AChR.
حسب: Zoltowska, K, وآخرون
منشور في: (2013)

Mutations in GFPT1 that underlie limb-girdle congenital myasthenic syndrome result in reduced cell-surface expression of muscle AChR
حسب: Zoltowska, K, وآخرون
منشور في: (2013)

Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations.
حسب: Burke, G, وآخرون
منشور في: (2013)

Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol.
حسب: Finlayson, S, وآخرون
منشور في: (2013)

The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes
حسب: Rodríguez Cruz, P, وآخرون
منشور في: (2018)

Chronic stridor as an early presentation of congenital myasthenic syndrome due to RAPSN mutation
حسب: Mewasingh, L, وآخرون
منشور في: (2006)

Myasthenic syndromes due to defects in COL13A1 and in the N‐linked glycosylation pathway
حسب: Beeson, D, وآخرون
منشور في: (2018)

DOK7 congenital myasthenic syndrome.
حسب: Palace, J
منشور في: (2012)

Congenital myasthenic syndrome patients due to AChR epsilon subunit mutations
حسب: Bonifati, D, وآخرون
منشور في: (2004)

The congenital myasthenic syndrome mutation RAPSN N88K derives from an ancient Indo-European founder
حسب: Muller, J, وآخرون
منشور في: (2004)

The congenital myasthenic syndrome mutation RAPSN N88K derives from an ancient Indo-European founder.
حسب: Müller, J, وآخرون
منشور في: (2004)

A rare c.183_187dupCTCAC mutation of the acetylcholine receptor CHRNE gene in a South Asian female with congenital myasthenic syndrome: a case report
حسب: Chang, T, وآخرون
منشور في: (2016)

Muscle magnetic resonance imaging in congenital myasthenic syndromes
حسب: Finlayson, S, وآخرون
منشور في: (2016)

Congenital myasthenic syndrome due to homozygous CHRNE mutations: report of patients in Arabia.
حسب: Salih, M, وآخرون
منشور في: (2011)

Arthrogryposis multiplex congenita associated with congenital myasthenic syndrome due to mutations in the acetylcholine receptor delta subunit
حسب: Brownlow, S, وآخرون
منشور في: (2000)

Congenital Myasthenic Syndrome with Agrin Mutations
حسب: J Gordon Millichap, وآخرون
منشور في: (2014-10-01)

Synaptic dysfunction in congenital myasthenic syndromes.
حسب: Beeson, D
منشور في: (2012)